<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39379864</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2431</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>BMC pediatrics</Title><ISOAbbreviation>BMC Pediatr</ISOAbbreviation></Journal><ArticleTitle>Kawasaki disease before and during the COVID-19 pandemic: a single-center comparative study in Switzerland.</ArticleTitle><Pagination><StartPage>637</StartPage><MedlinePgn>637</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">637</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12887-024-05115-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Kawasaki disease is a rare systemic inflammatory syndrome that mainly affects children under five years of age and is the first cause of pediatric acquired cardiovascular disease. The pathogenesis is complex and a viral trigger is suspected, as well as genetic susceptibility. Multiple studies around the world have shown a decrease in the incidence of Kawasaki disease and have hypothesized that the different sanitary measures enforced in each country during the pandemic period could be responsible to a certain extent. The aim of this study is to evaluate the effects of the COVID-19 pandemic on the disease's incidence, defining characteristics, coronary artery outcomes and management in a tertiary center in Switzerland.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study is a retrospective analysis of children who have been diagnosed with Kawasaki disease that compares clinical, laboratory, SARS-CoV-2 exposure, and echocardiographic data as well as treatments before (January 1st 2017 to February 24th 2020) and during (February 25th 2020 to December 31st 2022) the COVID-19 pandemic in Switzerland. Statistical significance of differences in the compared parameters was assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 90 patients included, 31 belonged to the first group and 59 belonged to the second group. There was a statistically significant (p &lt; 0.05) increase in incidence during the pandemic period (5.91/100,000 children) of 88% compared to the pre-pandemic period (3.14/100,000 children). A lesser seasonal variation was observed during the pandemic. 30% of the patients in the pandemic group had an exposure to SARS-CoV-2. There was no other notable difference in demographic factors, clinical presentation, coronary outcome or administered treatment.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To the best of our knowledge, this is the first prolonged European study comparing Kawasaki disease before and during the COVID-19 pandemic. There was a significant increase in incidence in Kawasaki disease during the COVID-19 pandemic. In contrast, studies done in Japan, South Korea and the USA have shown a decrease in incidence. Differences in methodologies, genetics, ethnicities, environments, microbiome-altering behaviors, sanitary measures and SARS-CoV-2 spread are factors that should be considered. Further studies analyzing the differences between countries with increased incidence of Kawasaki disease could help better understand the relevance of such factors and provide more insight into the etiologies of this particular disease.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Epitaux</LastName><ForeName>Justine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 21, Lausanne, 1011, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekarski</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of woman-mother-child, Unit of Pediatric Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 21, Lausanne, 1011, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bressieux-Degueldre</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of woman-mother-child, Unit of Pediatric Cardiology, Lausanne University Hospital, Rue du Bugnon 21, Lausanne, 1011, Switzerland. sabrina.bressieux@chuv.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pediatr</MedlineTA><NlmUniqueID>100967804</NlmUniqueID><ISSNLinking>1471-2431</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009080" MajorTopicYN="Y">Mucocutaneous Lymph Node Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013557" MajorTopicYN="N" Type="Geographic">Switzerland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">Coronary artery outcome.</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Kawasaki disease</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39379864</ArticleId><ArticleId IdType="pmc">PMC11460099</ArticleId><ArticleId IdType="doi">10.1186/s12887-024-05115-0</ArticleId><ArticleId IdType="pii">10.1186/s12887-024-05115-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCrindle BW, Rowley A, Newburger J, Burns J, Bolger A, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: A Scientific Statement for Health professionals from the American Heart Association. Circulation. 2017. 10.1161/CIR.0000000000000484.</Citation><ArticleIdList><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Newburger J, Takahashi M, Burns J, Beiser A, Chung K, Duffy CGM, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986. 10.1056/NEJM198608073150601.</Citation><ArticleIdList><ArticleId IdType="pubmed">2426590</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley A, Shulman S. The epidemiology and Pathogenesis of Kawasaki Disease. Front Pead. 2018. 10.3389/fped.2018.00374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298241</ArticleId><ArticleId IdType="pubmed">30619784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Lu C, Shao P, Lee P, Lin M, Fan T, et al. Viral infections associated with Kawasaki disease. J Formos Med Assoc. 2014. 10.1016/j.jfma.2013.12.008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125523</ArticleId><ArticleId IdType="pubmed">24495555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rife E, Gedalia A. Kawasaki Disease: an update. Curr Rheumatol Rep. 2020. 10.1007/s11926-020-00941-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487199</ArticleId><ArticleId IdType="pubmed">32924089</ArticleId></ArticleIdList></Reference><Reference><Citation>Gradoux E, Di Bernardo S, Bressieux-Degueldre S, Mivelaz Y, Boulos Ksontini T, Prsa M, et al. Epidemiology of Kawasaki Disease in children in Switzerland: a national prospective cohort study. Swiss Med Wkly. 2022. 10.4414/smw.2022.w30171.</Citation><ArticleIdList><ArticleId IdType="pubmed">35748748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh P, Katkar G, Shimizu C, Kim J, Khandelwal S, Tremoulet A, et al. An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease. Nat Commun. 2022. 10.1038/s41467-022-30357-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110726</ArticleId><ArticleId IdType="pubmed">35577777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Xu B, Du J. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment. World J Pediatr. 2021. 10.1007/s12519-021-00435-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134825</ArticleId><ArticleId IdType="pubmed">34013488</ArticleId></ArticleIdList></Reference><Reference><Citation>Office fédéral de la santé publique. Le Conseil Fédéral admin.ch. [Online].; 2020 [cited 2024 February 10. https://www.admin.ch/gov/fr/accueil/documentation/communiques.msg-id-78233.html</Citation></Reference><Reference><Citation>World Health Organization. [Online]. [cited 2024 April 1. https://www.who.int/europe/emergencies/situations/covid-19</Citation></Reference><Reference><Citation>Dallaire F, Dahdah N. New equations and a critical Appraisal of Coronary artery Z scores in healthy children. J Am Soc Echocardiogr. 2011. 10.1016/j.echo.2010.10.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">21074965</ArticleId></ArticleIdList></Reference><Reference><Citation>Etat de, Vaud. Tableaux de l’annuaire statistique (Cantons of Fribourg, Jura, Neuchâtel, Valais, Vaud). [Online].; 2021 [cited 2024 February 8. https://www.vd.ch/themes/etat-droit-finances/statistique/publications/annuaire-statistique/tableaux-de-lannuaire-statistique</Citation></Reference><Reference><Citation>Burney J, Roberts S, DeHaan L, Shimizu C, Bainto E, Newburger J, et al. Epidemiological and clinical features of Kawasaki Disease during the COVID-19 pandemic in the United States. JAMA Netw. 2022. 10.1001/jamanetworkopen.2022.17436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9206189</ArticleId><ArticleId IdType="pubmed">35713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B, Choi A, Kim H, Oh J, Lee J, Kim S, et al. Changes in the clinical characteristics of Kawasaki Disease after Coronavirus Disease (COVID-19) pandemic: a database analysis. J Korean Med Sci. 2022. 10.3346/jkms.2022.37.e141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127427</ArticleId><ArticleId IdType="pubmed">35607738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J, Kim Y, Huh K, Hong J, Kim D, Kim M, et al. Reduction in Kawasaki Disease after nonpharmaceutical interventions in the COVID-19 era. Wolters Kluwer. 2021. 10.1161/CIRCULATIONAHA.121.054785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212882</ArticleId><ArticleId IdType="pubmed">34092115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ae R, Makino N, Kuwabara M, Matsubara Y, Kosami K, Sasahara T, et al. Incidence of Kawasaki Disease before and after the COVID-19 pandemic in Japan: results of the 26th Nationwide Survey, 2019 to 2020. JAMA Pediatr. 2022. 10.1001/jamapediatrics.2022.3756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9577881</ArticleId><ArticleId IdType="pubmed">36251290</ArticleId></ArticleIdList></Reference><Reference><Citation>Iio K, Matsubara K, Miyakoshi C, Ota K, Yamaoka R, Eguchi J, et al. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan. BMJ Paediatrics Open. 2021. 10.1136/bmjpo-2021-001034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023747</ArticleId><ArticleId IdType="pubmed">33884312</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeilzadeh H, Mortazavi N, Salehi A, Fatemian H, Dehghani S, Vali M, et al. Effect of COVID-19 on Kawasaki Disease: decrease age of onset and increase skin manifestation. BMC Pediatr. 2021. 10.1186/s12887-021-03060-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8666466</ArticleId><ArticleId IdType="pubmed">34903208</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y, et al. JCS/JSCS 2020 Guideline on diagnosis and management of Cardiovascular Sequelae in Kawasaki Disease. Japanese Circulation Soc. 2020. 10.1253/circj.CJ-19-1094.</Citation><ArticleIdList><ArticleId IdType="pubmed">32641591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q, Zeng R, Ye J. Alteration of the oral and gut microbiota in patients with Kawasaki disease. PeerJ. 2023. 10.7717/peerj.15662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10340105</ArticleId><ArticleId IdType="pubmed">37456866</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Qian F, Zhang Q, Zhao J, Cen J, Zhang J, et al. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease. Front Immunol. 2023. 10.3389/fimmu.2023.1124118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10309029</ArticleId><ArticleId IdType="pubmed">37398673</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhim J, Kang H, Han J, Lee K. A presumed etiology of Kawasaki Disease based on Epidemiological Comparison with infectious or Immune-mediated diseases. Front Pead. 2019. 10.3389/fped.2019.00202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536658</ArticleId><ArticleId IdType="pubmed">31165053</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol. 2020. 10.1038/s41584-020-0426-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250272</ArticleId><ArticleId IdType="pubmed">32457494</ArticleId></ArticleIdList></Reference><Reference><Citation>Querdasi F, Vogel S, Thomason M, Callaghan B, Brito N. A comparison of the infant gut microbiome before versus after the start of the covid-19 pandemic. Sci Rep. 2023. 10.1038/s41598-023-40102-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10432475</ArticleId><ArticleId IdType="pubmed">37587195</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano-Keeler J, Zhang J, Sun J. COVID-19 and the neonatal microbiome: will the pandemic cost infants their microbes? Gut Microbes. 2021. 10.1080/19490976.2021.1912562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8115548</ArticleId><ArticleId IdType="pubmed">33960272</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020. 10.1016/S0140-6736(20)31103-X.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A, Bonacorsi S, et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health. 2020. 10.1016/S2352-4642(20)30175-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332278</ArticleId><ArticleId IdType="pubmed">32622376</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 2020. 10.1136/annrheumdis-2020-217960.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299653</ArticleId><ArticleId IdType="pubmed">32527868</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. JAMA. 2020 Jul 21;324(3):259-269. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ae R, Shibata Y, Kosami K, Nakamura Y, Hamada H. Kawasaki Disease and Pediatric Infectious diseases during the Coronavirus Disease 2019 Pandemic. J Pediatr. 2021. 10.1016/j.jpeds.2021.07.053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591269</ArticleId><ArticleId IdType="pubmed">34324881</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Ni C, Xia Y, Li J, Hang B, Han C, et al. Characteristics of Kawasaki Disease before and after the COVID-19 pandemic in a large Pediatric Heart Disease Center. Front Pead. 2022. 10.3389/fped.2022.895408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9152138</ArticleId><ArticleId IdType="pubmed">35656374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>